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FormalinAbstract Aim and objectives: Leaf extracts and fractions of S. bispinosa were evaluated for
anti-inflammatory activity in mice using acute and chronic anti-inflammatory models with aspirin
as a reference drug.
Materials and methods: Methanol, chloroform and hexane were used to prepare leaf extracts by
soxhlet extraction method, while acetone, ethyl acetate and petroleum ether were used to prepare
fractions of most active extract. These extract and fractions were evaluated by using carrageenan
and formalin-induced inflammation models in albino mice. Extracts and fractions at the dose
250 mg/kg/p.o. and aspirin at 100 mg/kg/p.o. were used for the study.
Results: Methanolic extract of S. bispinosa (MELSB) revealed significant anti-inflammatory
activity which is indicated by 15.22% inhibition of paw edema at 180 min in carrageenan model,
while ethyl acetate fraction of methanolic extract showed 16.26% and 15.50% inhibition of paw
edema and thickness in carrageenan and formalin models respectively. In chronic model, just like
aspirin, time-dependent activity was observed with acetone and ethyl acetate fractions; the greater
reduction in paw thickness was observed with ethyl acetate fraction (**p< 0.01).
Conclusion: The results of the present study suggest that leaves of S. bispinosa possess significant
level of anti-inflammatory activity and ethyl acetate fraction may be further explored as an
anti-inflammatory remedy as it was found to possess higher anti-inflammatory activity among all
extracts and fractions as demonstrated in both acute and chronic models.
 2015 The Authors. Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).1. Introduction
Inflammation is a normal, protective response of living tissues
against stimulus. First of all Aurelius Cornelius explained
clinical features and hallmarks of inflammation.1,2 Apart from
the type of stimuli, restoring normal homeostasis is initiated by
290 G.D. Boddawar et al.complex physiological process of innate immunity, mediated
by pro-inflammatory cells (leukocytes, neutrophils, macro-
phages & mast cells, etc.) which secrete a number of inflamma-
tory mediators (cyclooxygenase-1, cyclooxygenase-2,
histamine etc.), activate enzymes to eliminate the initial cause
of cell injury, & remove necrotic cells that causes inflamma-
tion.3–6
Inhibition of the therapeutic targets (cyclooxygenase-1,
cyclooxygenase-2, histamine receptor, etc.) is a potential
strategy to control inflammation, and is concerned with the
mechanism of action of gluco-corticoids and non-steroidal
anti-inflammatory drugs (NSAIDs). Majority of the currently
available anti-inflammatory drugs are associated with gas-
trointestinal, renal system, cardiovascular and other risks.7–11
Apart from the synthetic drugs, the number of plants has
significant potential to inhibit inflammatory diseases because,
it contains a multitude of different molecules that act synergis-
tically on targets of the complex physiological pathways and
have found widely used because of several reasons such as
awareness about plant-based remedies, the lower cost of
phyto-therapy, the fear about the possible side effects of allo-
pathic medicine, phyto-constituents are having low animal and
human toxicity and have a higher bioavailability and therefore
higher protective efficacy than synthetic drugs.12–16 So, it is
need of time to invent and evaluate more and more herbal
drugs with high therapeutic activity, bioavailability and less
toxicity.
Sesbania bispinosa Linn., (Fabaceae) is wild shrub and also
cultivated throughout India as its leaves are used as fodder
especially for sheep & goats in summer seasons17 and leaves
are good source of protein supplementation with high quality
nutrients. The various parts of S. bispinosa showed the pres-
ence of phyto-constituents such as; flavonols, tannins, sapo-
nins, phytosterols, anthocyanins, alpha-ketoglutaric acid,
oxaloacetic acid, and pyruvic acid 18–20 It is traditionally used
in Indian folk medicines for various ailments. Roots are used
as contraceptive, hepato-protective, anti-helminthic & carmi-
native. It is also used for the cure of tuberculous glands in dys-
uria, in retention of urine, leucoderma & as an anti-dote in
scorpion stings, for the relief of fever, ulcer, diabetes etc. Root
and bark are used as bitter tonic, nervous disorders, as central
nervous system stimulant.18,19 Barks are also used to treat the
ulcer, leucorrhea, vitiated conditions of pitta, anemia, bronchi-
tis, tumor, dysentery, inflammations, cirrhosis of liver and
hypertension. Seeds are emmenagogue, stimulant, astringent
and also used in treatment of diarrhea, excessive menstrual
flow, to reduce enlargement of spleen and skin disease. Its
leaves are useful in diabetes, colic, skin diseases, as anti-
helmintic and also in inflammatory rheumatic condi-
tions.18,21–23 However, anti-inflammatory effects are not yet
experimentally proved. Hence the present study aimed to eval-
uate anti-inflammatory activity of leaves of S. bispinosa by
acute and chronic models.2. Material and methods
2.1. Collection and identification of plant
The leaves of S. bispinosa were collected in the month of
December, 2014, from local area of Kandhar Dist. Nanded,
Maharashtra, India. The plant was identified as S. bispinosaLinn., belonging to a family of Fabaceae, by P.G Department
of Botany, N.E.S. Science College, Nanded, Maharashtra,
India, with a voucher specimen no. Auth: S-1/26/08/13.
2.2. Chemicals
All chemicals used in the study were of laboratory grade:
methanol, chloroform, hexane, petroleum ether, ethyl acetate,
acetone, acetic anhydride, carrageenan, formalin, Tween 80,
carboxy methyl cellulose and aspirin and were obtained from
S.D. Fine chemicals, Mumbai, India.
2.3. Preparation of extracts and fractions
The leaves were washed with distilled water and shed dried to
prepare the coarse powder. The powder of S. bispinosa was
extracted employing solvents such as methanol, chloroform
and hexane by using Soxhlet apparatus.24 Most effective
extract (methanol extract) obtained in carrageenan-induced
paw edema test, was suspended in distilled water (1:3, v/v)
and successively fractioned with petroleum ether, ethyl acetate
and acetone. All the fractions obtained were dried with rotary
evaporator and kept at 2–8 C until the time of use.25
2.4. Experimental animals
Swiss albino mice of either sex weighing 25–30 g were used.
They were housed under standard laboratory conditions at
23 C (±3 C) temperature and 12 h light and dark cycle main-
tained, free access to standard pellet diet and water ad libitum.
The Institutional Animal Ethics Committee approved the
experimental protocol (IAEC resolution number: 3-X dated
22/06/2014).
2.5. Anti-inflammatory activity
2.5.1. Carrageenan-induced paw edema test
All extracts and fractions were administered with the gastric
gavage and 50 ll of 1% v/v of carrageenan was injected in
the left hind paw subplantar region after 30 min of oral admin-
istration of test extracts and aspirin.26,27 The paw volume was
measured by Plethysmometer (ORCHID Scientific & Innova-
tive India, Pvt. Ltd. India). Before injecting carrageenan, the
average volume of the right and left hind paw of each mouse
was measured at 30 min, 60 min, 120 min, and 180 min after
injection.1 Animals were categorized into control and test
groups; control group represented negative control (without
treatment of standard/extracts/fractions) and positive control
(standard i.e. aspirin).
2.5.1.1. Anti-inflammatory activity of extracts. Five groups of
six animals each of either sex were used: Group I (negative
control) received suspension of 1% CMC (Carboxymethyl Cel-
lulose) at the dose of 10 ml/kg.p.o.; Group II (positive control)
received suspension of aspirin at the dose of 100 mg/kg.p.o.;
Groups III–V served as treatment (250 mg/kg.p.o.); Group
III received suspension of methanolic extract of leaves of S.
bispinosa (MELSB); Group IV received suspension of chloro-
form extract of leaves of S. bispinosa (CELSB); and Group
V received suspension of hexane extract of leaves of S. bispi-
nosa (HELSB).
Assessment of anti-inflammatory potential and fractions 2912.5.1.2. Anti-inflammatory activity of fractions. Group I (nega-
tive control): This group received suspension of 1% CMC at
the dose of 10 ml/kg.p.o. Group II (positive control): This
group received suspension of aspirin at the dose of 100 mg/
kg.p.o. Group III: This group received suspension of acetone
fraction (AF) of MELSB. Group IV: This group received sus-
pension of ethyl acetate fraction (EAF) of MELSB. Group V:
This group received suspension of petroleum ether fraction
(PEF) of MELSB.
2.5.2. Formalin-induced arthritis
Five groups of six animals each of either sex were used. Group
I (negative control): This group received suspension of CMC
at the dose of 10 ml/kg.p.o. Group II (positive control): This
group received suspension of aspirin at the dose of 100 mg/
kg.p.o. Group III–V served as treatment (250 mg/kg.p.o).
Group III: This group received suspension of acetone fraction
(AF) of MELSB. Group IV: This group received suspension of
ethyl acetate fraction (EAF) of MELSB. Group V: This group
received suspension of petroleum ether fraction (PEF) of
MELSB. All the groups were fed with the gastric gavage and
injected with 0.02 ml of 2.5% v/v of formalin solution in the
left hind paw in subplantar region after 30 min of oral admin-
istration of standard drug/test/vehicle on day 1.28,29 The mice
were then treated with different fractions/drug/vehicle for
7 days. The paw thickness of each mouse was measured by
using Vernier caliper daily before treatment.1
3. Statistical test
All the data were statistically analyzed using ANOVA fol-
lowed by Dunnett test. Values are expressed as Mean ± SD
(n= 6). Level of significance set as *p< 0.05, **p < 0.01 when
compared with control.4. Results
4.1. Carrageenan-induced paw edema test
The average left hind paw volumes are presented in Table 1.
For the control group, the injection of carrageenan caused
localized edema, after 30 min. The swelling increased progres-
sively from 30 min onwards. A maximum volume of paw was
observed in animals of negative control at 180 min (0.289
± 0.008 ml) after carrageenan injection. MELSB and HELSB
caused significant decrease in the paw volume (**p < 0.01)Table 1 Influence of extracts of leaves of S. bispinosa on carrageen
Groups Paw Volume (ml)
0 min 30 min 60 min
Negative control 0.117 ± 0.016 0.17 ± 0.015 0.22 ± 0.018
Aspirin 0.11 ± 0.018 0.13 ± 0.015** 0.157 ± 0.014*
MELSB 0.107 ± 0.017 0.14 ± 0.009** 0.172 ± 0.008*
CELSB 0.117 ± 0.016 0.157 ± 0.006 0.22 ± 0.016
HELSB 0.12 ± 0.018 0.154 ± 0.006** 0.19 ± 0.011*
Values are expressed as Mean ± SD. (n= 6), ANOVA followed by Dun
*p< 0.05, when compared with negative control.
** p< 0.01, when compared with negative control.(0.289 ± 0.008 to 0.245 ± 0.011 and 0.259 ± 0.008) with
15.22% and 12.11% inhibition of inflammation respectively.
The standard drug, aspirin significantly reduced (**p < 0.01)
the paw edema (0.204 ± 0.013 i.e. 29.41% inhibition of
inflammation). The results reveal that the chloroform extract
lacked anti-inflammatory activity while methanolic extract
(MELSB) significantly inhibited inflammation.
As seen from Table 2, ethyl acetate fraction (EAF) of
MELSB demonstrated significant reduction (**p < 0.01) in
the paw volume of mice induced by carrageenan; decreasing
the paw volume from 0.289 ± 0.008 (in the negative control)
to 0.242 ± 0.015** (**p< 0.01) at the dose of 250 mg/kg/p.o.
amounting 16.26% inhibition of paw volume which was com-
parable to aspirin, which reduced paw volume to 0.204
± 0.013** (**p < 0.01) at 100 mg/kg/p.o. AF of MELSB also
demonstrated significant anti-inflammatory activity, whereas,
PEF exerted significant but lesser activity as compared to other
fractions.
4.2. Formalin-induced arthritis
Fig. 1 depicts the formalin-induced left hind paw thickness
results. Administration of formalin caused increase in paw
thickness in all groups. In case of negative control, the highest
increase in paw thickness was observed on day 3 and slowly
reduced, but not restored to its original paw thickness which
was on day 1.
Formalin-induced paw thickness was reduced significantly
(**p < 0.01) with administration of AF, EAF and PEF which
was found to be time-dependent and highest reduction in paw
thickness was observed on day 8. EAF showed highest activity
among all fractions and its anti-inflammatory effects were
comparable to aspirin.
5. Discussion
The use of medicinal plants has been an important alternative
as therapeutic source of treatment of various diseases and dis-
orders. Its rising acceptance in the medical community has
been due to the fact that several plants with novel biologically
active compound have been scientifically investigated and their
efficacy and safety have been verified.30 The continuous
research in the field of synthetic drugs in recent years is accom-
panied by numerous unwanted side effects, such as NSAIDs
that have gastric ulcer and glucocorticoids are associated with
adrenal suppression, as major side effects but plants have their
unique place with least side effects.10,11,15an-induced paw edema.
% inhibition at 180 min
120 min 180 min
0.265 ± 0.016 0.289 ± 0.008
* 0.182 ± 0.014** 0.204 ± 0.013** 29.41%
* 0.209 ± 0.008** 0.245 ± 0.011** 15.22%
0.26 ± 0.009 0.287 ± 0.009 0.69%
* 0.23 ± 0.009** 0.254 ± 0.008** 12.11%
nett test.
Table 2 Influence of fractions of methanolic extract of leaves of S. bispinosa on carrageenan-induced rat paw edema.
Groups Paw volume (ml) % inhibition at 180 min
0 min 30 min 60 min 120 min 180 min
Negative control 0.117 ± 0.016 0.17 ± 0.015 0.22 ± 0.018 0.265 ± 0.016 0.289 ± 0.008
Aspirin 0.11 ± 0.018 0.13 ± 0.015** 0.157 ± 0.014** 0.182 ± 0.014** 0.204 ± 0.013** 29.41%
AF 0.109 ± 0.015 0.144 ± 0.013** 0.182 ± 0.012** 0.219 ± 0.015** 0.255 ± 0.011** 11.76%
EAF 0.105 ± 0.014 0.142 ± 0.010** 0.175 ± 0.014** 0.205 ± 0.006** 0.242 ± 0.015** 16.26%
PEF 0.117 ± 0.019 0.155 ± 0.009 0.189 ± 0.014** 0.229 ± 0.012** 0.264 ± 0.011** 8.65%
Values are expressed as Mean ± SD. (n= 6), ANOVA followed by Dunnett test.
*p < 0.05, when compared with negative control.

























Figure 1 The paw thickness of various fractions of MELSB.
EAF exhibits time-dependent anti-inflammatory effects in a
similar fashion to that of aspirin.
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inflammatory efficacy of S. bispinosa in carrageenan and
formalin-induced mice paw edema and thickness models.
Carrageenan-induced paw edema is a popular and widely
accepted acute model for the study of anti-inflammatory activ-
ity of compounds such as both steroidal anti-inflammatory
drugs and NSAIDs.1,31 The local injection of carrageenan
induces inflammatory reaction in two different phases. The ini-
tial phase (0–1 h) has been accredited to the action of inflam-
matory mediators such as histamine, 5-HT, bradykinin and
serotonin on vascular permeability. The late phase (1–6 h) is
a result of overproduction of prostaglandins.
The inflammatory reaction involves three phases through
orderly release of several mediators. The early phase (the first
90 min) has been attributed to the release of histamine and
serotonin; the second phase (1.5–2.5 h) is the result of kinin
and prostaglandins, while in the third phase (after 3 h) mainly
involves action of prostaglandins with development of hyperal-
gesia due to increase of cyclooxygenase-2 level, and its peak
reaches in within 4 h after carrageenan injection.32,33
In the present investigation, animals treated with MELSB
and HELSB demonstrated significant reduction in paw vol-
ume. More active fraction, MELSB was selected for further
fractionation using various solvents such as ethyl acetate, ace-
tone and petroleum ether and these fractions were evaluated
for anti-inflammatory activity by both acute and chronicmodels i.e. carrageenan and formalin induced paw edema.
Results obtained from the carrageenan-induced paw swelling
test revealed that EAF and AF of MELSB possess time-
dependent significant anti-inflammatory activity while PEF
of MELSB showed little late anti-inflammatory effect. The
findings of this study suggest that the methanolic extract and
fractions thereof may possibly act by inhibiting the release or
action of histamine, serotonin and kinin and prostaglandin.
Formalin-induced arthritis model is most suitable for
screening of anti-inflammatory and anti-arthritic compounds.
This model predicts anti-proliferative effects of agents.34 Injec-
tion of formalin into hind paw produces localized pain and
inflammation, which is biphasic response, an early neurogenic
component followed by a later tissue-mediated response.1 AF,
EAF and PEF of MELSB have shown marked inhibition of
inflammation. Time-dependent activity was observed with
AF and EAF, and the greater reduction in paw thickness
was observed with ethyl acetate fraction (**p< 0.01) just like
aspirin. This indicates that EAF and AF of MELSB actions
confirm its anti-proliferative effect and EAF may further be
explored for its use in arthritis.
In both the models, ethyl acetate fraction has shown greater
anti-inflammatory effects as compared to acetone and petro-
leum ether fractions. Interestingly, acetone fraction showed
more inhibition of inflammation in acute model and less
activity in chronic model than petroleum ether fraction. It indi-
cates that the PEF is having components which inhibit late
phase inflammatory mediators and AF possesses the phyto-
constituents responsible for inhibition of early phase inflam-
matory mediators. The observed anti-inflammatory effects of
extracts and fractions may be attributed to the presence of ster-
oids, triterpenoids, alkaloids, saponins, flavonoids and phenols
which may be responsible for inhibition of inflammatory medi-
ators such as histamine, 5-hydroxytryptamine, bradykinin,
serotonin and prostaglandins.35 Further the role of sterols
for the observed anti-edema effect cannot be ruled out as these
are present in S. bispinosa and several studies have demon-
strated anti-inflammatory effects of phytosterols.18–20,366. Conclusion
Findings of the present study suggest that ethyl acetate fraction
of S. bispinosa leaves possesses significant anti-inflammatory
activity, as demonstrated in both acute and chronic models
and may be further explored as an anti-inflammatory remedy.
However, isolation, separation and identification specific
component responsible for anti-inflammatory activity of ethyl
acetate fraction may be required.
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